Skip to main content
☰
moat
keep
Markets
News
Screener
Research
Editorials
Pricing
About
⌘K
Sign in
Start free
Lakewood-Amedex Biotherapeutics Inc. (LABT) stock — financials, valuation and filings | Moatkeep
Companies
/
Nasdaq
/
LABT
Lakewood-Amedex Biotherapeutics Inc.
LABT · Nasdaq
$0.24
−16.74%
Close, 2026-10-29
Close, 2026-10-29 · source: Databento · USD · figures not investment advice
+ Alert
★ Watchlist
Overview
News
Valuation
Financials
Reports
Editorials & Research
Business
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
MAX
⤢ Expand
Price
▾
Log
Volume
Events
▾
Window
-99.7%
vs high
-99.7%
Price
through 2026-10-29
ex-date (0) · fiscal quarter (0)
Dividends: company filings (SEC EDGAR) and the historical exchange record.
State of incorporation
NV
Fiscal year end
Dec 31
Financials · latest year
USD millions
FY2026
Net Income
-4
FY0
•••••
•••••
Read the full financial statements
Create a free account to see 5 years of financial history
Create a free account
Source: SEC EDGAR (XBRL) · figures in USD millions
View full financials →
Related companies
GOVX
—
GeoVax Labs, Inc.
IMTE
—
Integrated Media Technology Ltd
IPST
—
IP STRATEGY HOLDINGS, INC.
NWGL
—
CL Workshop Group Ltd
ITP
—
IT TECH PACKAGING, INC.
XAIR
—
Beyond Air, Inc.
OGEN
—
ORAGENICS INC
VVOS
—
Vivos Therapeutics, Inc.